alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 520.2044 Pyrantel pamoate paste. ( a ) *Specifications* — ( 1 ) Each milliliter (mL) contains 180 milligrams (mg) pyrantel base (as pyrantel pamoate).
( 2 ) Each mL contains 226 mg pyrantel base (as pyrantel pamoate).
( 3 ) Each mL contains 171 mg pyrantel base (as pyrantel pamoate).
( b ) *Sponsors.* See sponsors in § 510.600(c) of this chapter. ( 1 ) No. 054771 for use of product described in paragraph (a)(1) of this section as in paragraph (d)(1)(i) and (d)(2) of this section.
( 2 ) No. 017135 for use of product described in paragraph (a)(2) of this section as in paragraph (d) of this section.
( 3 ) No. 061133 for use of product described in paragraph (a)(3) of this section as in paragraph (d)(1)(i) and (d)(2) of this section.
( c ) *Special considerations.* See § 500.25 of this chapter.
( d ) *Conditions of use.* It is used in horses and ponies as follows: ( 1 ) *Amounts and indications for use.* (i) 3 mg per pound (/lb) body weight as single oral dose for removal and control of infections from the following mature parasites: large strongyles (*Strongylus vulgaris*, *S. edentatus*, *S. equinus*); small strongyles; pinworms (*Oxyuris equi*); and large roundworms (*Parascaris equorum*). ( ii ) 6 mg/lb body weight as single oral dose for the removal and control of mature infections of tapeworms (*Anoplocephala perfoliata*).
( 2 ) *Limitations.* Do not use in horses intended for human consumption.
[70 FR 29447, May 23, 2005, as amended at 76 FR 17337, Mar. 29, 2011; 78 FR 17596, Mar. 22, 2013; 79 FR 28827, May 20, 2014; 81 FR 17607, Mar. 30, 2016; 84 FR 8973, Mar. 13, 2019]
SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   ----------

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES ExCHANGE ACT OF 1934

Date of report (date of earliest event reported): April 24, 2003

                               TELULAR CORPORATION
             (Exact Name of Registrant as Specified in Its Charter)

           Delaware                  0-23212                    36-3885440
(State or Other Jurisdiction      (Commission                (I.R.S. Employer
      of Incorporation)           File Number)            Identification Number)

       647 North Lakeview Parkway, Vernon Hills, Illinois         60061
            (Address of Principal Executive Offices)            (Zip Code)

                        (847) 247-9400
      (Registrant's Telephone Number, Including Area Code)

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.

         (c)   Exhibits

         99.1  Press Release issued by Telular Corporation dated April 24, 2003.

Item 9. Regulation FD Disclosure.

      On April 24, 2003, Telular Corporation issued a press release reporting
its fiscal year 2003 second quarter results. This press release is attached
hereto as Exhibit 99.1 and is being furnished, not filed, under item 9 to this
Report on Form 8-K.

Item 12. Results of Operations and Financial Condition.

      On April 24, 2003, Telular Corporation issued a press release reporting
its fiscal year 2003 second quarter results. This press release is attached
hereto as Exhibit 99.1 and is being furnished, not filed, under item 9 to this
Report on Form 8-K.
<PAGE>

                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

      Date: April 24, 2003

                                       TELULAR CORPORATION

                                       /s/ JEFFREY L. HERRMANN
                                       -----------------------------------------
                                       Jeffrey L. Herrmann
                                       Executive Vice President, Chief Operating
                                       Officer and Chief Financial Officer

Exhibit Index

Sequential
Exhibit
Number                  Document Name

99.1                    Press Release dated April 24, 2003
Section 1350 Certification
 

      I, Shaun  O'Brien,  the Chief  Financial  Officer of CIS  Investments,  Inc.  ("CISI"),  the General Partner ofIDS Managed Futures II, L.P.(the "Partnership"),  and I, James A.  Davison,  the  President of CISI,  certify that (i) the attached  10-Q fullycomplies with the  requirements  of Section 13(a) or 15(d) of the Securities  Exchange Act of 1934 and (ii) the informationcontained in the attached Form 10-Q fairly  presents,  in all material  respects,  the  financial  condition and results ofoperations of the Partnership.
 

 
James A. Davison         President         CIS Investments, Inc.        November 12, 2003 Shaun D. O'Brien         Chief Financial Officer         CIS Investments, Inc.        November 12, 2003
##### 



Exhibit 10.3
  Via
Facsimile and Overnight Courier
 YOUBET.COM, INC.
 Re:
    
    Waiver of Events of Default
  Credit
Agreement WELLS FARGO FOOTHILL, INC. Agent YOUBET.COM, INC. Administrative Borrower Borrowers Lenders
 Known Existing Defaults




---



##### 



Very truly yours,WELLS FARGO FOOTHILL, INC.,as Agent and as a LenderBy:
    
    /s/ Michael GanannName:
    
    Michael GanannTitle:
    
    Vice PresidentACKNOWLEDGED AND AGREED:ADMINISTRATIVE BORROWERYOUBET.COM, INC.,a Delaware corporationBy:
    
    /s/ James A. Burk           8/5/07Name:
    
    James A. BurkTitle:
    
    CFO
Exhibit 24

 

**POWEROF ATTORNEY**

 

KNOWALL MEN BY THESE PRESENTS, that the undersigned director of RETRACTABLETECHNOLOGIES, INC., a Texas corporation (the “Corporation”), does hereby make, constitute,and appoint MARCO LATERZA, and each or any one of them, the undersigned’strue and lawful attorneys-in-fact, with full power of substitution, for theundersigned and in the undersigned’s name, place and stead, to sign and affixthe undersigned’s name as director of the Corporation to the Form 10-K forthe year ended December 31, 2008, and to file the same, including any andall exhibits, schedules, supplements, certifications, supporting documents, andamendments thereto.

 

Theundersigned also grants to said attorneys-in-fact, and each of them, full powerand authority to do and perform any and all acts necessary or incidental to theperformance and execution of the powers herein expressly granted, herebyratifying and confirming all that said attorneys-in-fact may lawfully do orcause to be done by virtue hereof.  ThisPower of Attorney shall remain in effect until revoked in writing by theundersigned.

 

INWITNESS WHEREOF, the undersigned has executed this Power of Attorney effectiveas of March 24, 2009.

 

 
|   | s/  Marwan Saker |
|--------|------------------|
|   | Marwan  Saker    |
|   | Director         |

 

----
§ 74.3045 [Phthalocyaninato(2-)] copper. ( a ) *Identity.* The color additive is [phthalocyaninato(2-)] copper (CAS Reg. No. 147-14-8) having the structure shown in Colour Index No. 74160.
( b ) *Specifications.* The color additive [phthalocyaninato(2-)] copper shall conform to the following specifications and shall be free from impurities other than those named to the extent that such impurities may be avoided by current good manufacturing practice: Volatile matter 135 °C (275 °F), not more than 0.3 percent. Salt content (as NaC1), not more than 0.3 percent. Alcohol soluble matter, not more than 0.5 percent. Organic chlorine, not more than 0.5 percent. Aromatic amines, not more than 0.05 percent. Lead (as Pb), not more than 40 parts per million. Arsenic (as As), not more than 3 parts per million. Mercury (as Hg), not more than 1 part per million. Total color, not less than 98.5 percent.
( c ) *Uses and restrictions.* ( 1 ) The color additive [phthalocyaninato(2-)] copper may be safely used to color polypropylene sutures, polybutester (the generic designation for the suture fabricated from 1,4-benzenedicarboxylic acid, polymer with 1,4-butanediol and *alpha*-hydro-*omega*-hydroxypoly(oxy-1,4-butanediyl), CAS Reg. No. 37282-12-5) nonabsorbable sutures for use in general and ophthalmic surgery, polybutylene terephthalate nonabsorbable monofilament sutures for general and ophthalmic surgery, nonabsorbable sutures made from poly(vinylidene fluoride) and poly(vinylidene fluoride-co-hexafluoropropylene) for general and ophthalmic surgery, polymethylmethacrylate monofilament used as supporting haptics for intraocular lenses, and polymers used in orientation marks for intraocular lenses, subject to the following restrictions: ( i ) The quantity of the color additive does not exceed 0.5 percent by weight of the suture, haptic material, or orientation mark.
( ii ) The dyed suture shall conform in all respects to the requirements of the U.S. Pharmacopeia.
( 2 ) The color additive [phthalocyaninato(2-)] copper may be safely used for coloring contact lenses in amounts not to exceed the minimum reasonably required to accomplish the intended coloring effect.
( 3 ) Authorization for these uses shall not be construed as waiving any of the requirements of section 510(k), 515, or 520(g) the Federal Food, Drug, and Cosmetic Act with respect to the medical device in which [phthalocyaninato(2-)] copper is used.
( d ) *Labeling.* The label of the color additive shall conform to the requirements of § 70.25 of this chapter.
( e ) *Certification.* All batches of [phthalocyaninato (2-)] copper shall be certified in accordance with regulations in part 80 of this chapter.
[48 FR 34947, Aug. 2, 1983, as amended at 50 FR 16228, Apr. 25, 1985; 51 FR 22929, June 24, 1986; 51 FR 28930, Aug. 13, 1986; 51 FR 39371, Oct. 28, 1986; 52 FR 15945, May 1, 1987; 55 FR 19620, May 10, 1990; 64 FR 23186, Apr. 30, 1999; 81 FR 75692, Nov. 1, 2016]
# C_2015354EN.01003602.xml

| 26.10.2015 | EN | Official Journal of the European Union | C 354/36 |
| --- | --- | --- | --- |

26.10.2015

EN

Official Journal of the European Union

C 354/36

---

Judgment of the General Court of 10 September 2015 — Laverana v OHIM (BIO CON ESTRATTI VEGETALI DI PRODUZIONE PROPRIA)

(Case T-572/14) (1)

1

((Community trade mark - Application for Community figurative mark BIO CON ESTRATTI VEGETALI DI PRODUZIONE PROPRIA - Absolute ground for refusal - Descriptive character - Article 7(1)(c) of Regulation (EC) No 207/2009))

(2015/C 354/43)

Language of the case: German

Parties

Parties

Applicant: Laverana GmbH & Co. KG (Wennigsen, Germany) (represented by: J. Wachinger, M. Zöbisch and D. Chatterjee, lawyers)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: A. Schifko, acting as Agent)

Defendant:

Re:

Re:

Action brought against the decision of the Fourth Board of Appeal of OHIM of 27 May 2014 (Case R 527/2014-4) concerning an application for registration of the figurative sign BIO CON ESTRATTI VEGETALI DI PRODUZIONE PROPRIA as a Community trade mark.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Laverana GmbH & Co. KG to bear the costs. |
| --- | --- |

2.

Orders Laverana GmbH & Co. KG to bear the costs.

---

(1)  OJ C 361, 13.10.2014.

1

---
- All
            - Title
            - Author
            - Subject
            - Date
            - Full-Text

            -                              Explore                            ******                - Educational Resources
              - Archival Collections
              -                                      Themes                                    ******                  - Economic Data
                - Federal Reserve
                - View all 
              - Timelines 
            -                              Browse                            ******                - Titles
              - Authors
              - Subjects
              - Dates 
            -                              About                            ******                - About FRASER
              - FAQ
              - Contact Us
              -                                      FRASER API                                    ******                  - REST API
                - OAI-PMH 
            - Inside FRASER Blog

            - **

Home                 > Browse by Title > Materials Prepared in Connection with the Study of Employment, Growth, and Price Levels for Consideration by the Joint Economic Committee, Congress of the United States

              																								United States. Congress. Joint Economic Committee, 1956-					 and 	Eighty-Sixth Congress, 1959-1961.						"Study Paper No. 22 : An Evaluation of Antitrust Policy : Its Relation to Economic Growth, Full Employment, and Prices" in *Materials Prepared in Connection with the Study of Employment, Growth, and Price Levels for Consideration by the Joint Economic Committee, Congress of the United States*			(January 30, 1960).						https://fraser.stlouisfed.org/title/1244/item/3646, accessed on September 26, 2024.	    

        - **FRASER**
        - About
        - FAQ
        - Legal and Privacy
        - FRASER API

          -                              @FedFRASER 
          - ** Contact Us
          -  **  What's New  
          -  **  Inside FRASER
# C_2015346EN.01002502.xml

| 19.10.2015 | EN | Official Journal of the European Union | C 346/25 |
| --- | --- | --- | --- |

19.10.2015

EN

Official Journal of the European Union

C 346/25

---

Judgment of the General Court of 9 September 2015 — Pérez Gutiérrez v Commission

(Case T-168/14) (1)

1

((Non-contractual liability - Public health - Directive 2011/37/EC - Manufacture, presentation and sale of tobacco products - Colour photographs proposed by the Commission as health warnings to appear on tobacco packages - Decision 2003/641/EC - Unauthorised use of the image of a deceased person - Harm suffered personally by the widow of the deceased person))

(2015/C 346/29)

Language of the case: Spanish

Parties

Parties

Applicant: Ana Pérez Gutiérrez (Mataró, Spain) (represented by: J. Soler Puebla, lawyer)

Applicant:

Defendant: European Commission (represented by: J. Baquero Cruz and C. Cattabriga, acting as Agents)

Defendant:

Re:

Re:

Action for damages seeking, firstly, compensation for the harm allegedly suffered by the applicant as a consequence of the unauthorised use of her late husband’s picture among the photographs proposed by the Commission for the health warnings to be shown on tobacco packages pursuant to the first subparagraph of Article 5(3) of Directive 2001/37/EC of the European Parliament and of the Council of 5 June 2001 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco products (OJ 2001 L 194, p. 26) and Commission Decision 2003/641/EC of 5 September 2003 on the use of colour photographs or other illustrations as health warnings on tobacco packages (OJ 2003 L 226, p. 24) and, secondly, the withdrawal of her late husband’s picture and a prohibition on its use within the European Union.

Operative part of the judgment

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Ms Ana Pérez Gutiérrez to pay the costs. |
| --- | --- |

2.

Orders Ms Ana Pérez Gutiérrez to pay the costs.

---

(1)  OJ C 135, 5.5.2014.

1

---
**Exhibit 31.2****Certifications**I, Thomas J. Koenig, certify that:1. I have reviewed this annual report on Form 10-K of Day International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have: a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relatingto the registrant, including its consolidated subsidiaries, is made known to us by otherswithin those entities, particularly during the period in which this report is being prepared;  b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; and  c) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (the registrant’sfourth fiscal quarter in the case of an annual report) that has materially affected, or isreasonably likely to materially affect, the registrant’s internal control over financialreporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of the registrant’s board of directors (or persons performing the equivalentfunctions): a) All significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and report financial information; and  b) Any fraud, whether or not material, that involves management or other employees who have asignificant role in the registrant’s internal control over financial reporting.        Date:     April 2, 2007 By:  /s/ Thomas J. Koenig    Thomas J. Koenig    Vice President and Chief Financial Officer(Principal Financial Officer and Principal Accounting Officer)
§ 660.22 Potency requirements with reference preparations. ( a ) *Potency requirements.* Products for which reference Blood Grouping Reagents are available shall have a potency titer value at least equal to that of the reference preparation.
( b ) *Reference preparations.* Reference Blood Grouping Reagents shall be obtained from the Food and Drug Administration, Center for Biologics Evaluation and Research, Reagents and Standards Shipping, 10903 New Hampshire Ave., Bldg. 75, Rm. G704, Silver Spring, MD 20993-0002, and shall be used as described in the accompanying package insert for determining the potency of Blood Grouping Reagents.
[53 FR 12764, Apr. 19, 1988, as amended at 67 FR 9587, Mar. 4, 2002; 70 FR 14985, Mar. 24, 2005; 80 FR 18093, Apr. 3, 2015]
#### Mary E. St. Pierre *v.*Stanley St. Pierre

King, C. J., Alcorn, House, Thim and Ryan, Js.

Argued October 15

decided October 28, 1969

*William R. Davis,*with whom, on the brief, was *Leon RisCassi,*for the appellant (plaintiff).

*Joseph T. Sweeney,*with whom, on the brief, was *Thomas J. Hagarty,*for the appellee (defendant).

Per Curiam.

Upon the authority of *Landers*v. *Landers,*153 Conn. 303, 216 A.2d 183, the court sustained a demurrer to the complaint. On this appeal, the sole assignment of error is addressed to this ruling. The basic claim of the plaintiff is that we should reexamine the holding of the *Landers*case and change our rule that the substantive internal law of the situs of a tort determines the capacity to sue as it may be affected by the marriage relationship. We see no reason to change our rule as enunciated in that case.

There is no error.
Exhibit 10.47


 


Employee Stock Ownership Plan of


 


Dime Community Bancshares, Inc. and Certain Affiliates 


 


Amendment Number Five


 


Amendment Number Five to the Employee Stock Ownership Plan of Dime Community Bancshares, Inc. and Certain Affiliates (the "ESOP).


 


The ESOP is hereby amended as follows:


 


All references in the ESOP to “The Dime Savings Bank of Williamsburgh” or the “Bank” shall be deemed to refer to “Dime Community Bank”.







This Amendment to the ESOP is effective as of_______________, 2016 and was executed on _______________, 2016.







	 	
DIME COMMUNITY BANCSHARES, INC.
I 

118TH CONGRESS 

2D SESSION H. R. 7313 

To require the Secretary of Defense to brief Congress on progress in capturing 

the leadership of the Jalisco New Generation Cartel. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 9, 2024 

Mr. LUTTRELL introduced the following bill; which was referred to the 

Committee on Armed Services 

A BILL 

To require the Secretary of Defense to brief Congress on 

progress in capturing the leadership of the Jalisco New 

Generation Cartel. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Jalisco Cartel Neutral5 ization Act’’. 

6 SEC. 2. CONGRESSIONAL BRIEFINGS ON THE DECAPITA7 TION OF THE JALISCO NEW GENERATION 

8 CARTEL. 

9 (a) BRIEFING REQUIREMENT.—Not later than 90 

10 days after the date of enactment of this Act, and every 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7313 IH

1 90 days thereafter, the Secretary of Defense shall provide 

2 a briefing to the appropriate committees of Congress on 

3 progress in capturing or killing the leadership of the 

4 Jalisco New Generation Cartel, also known as Cartel 

5 Jalisco Nueva Generacio ́n. 

6 (b) APPROPRIATE COMMITTEES OF CONGRESS.—In 

7 this section, the term ‘‘appropriate committees of Con8 gress’’ means— 

9 (1) the Committee on the Judiciary, the Com10 mittee on Armed Service, the Committee on Foreign 

11 Relations, the Committee on Homeland Security and 

12 Governmental Affairs, and the Select Committee on 

13 Intelligence of the Senate; and 

14 (2) the Committee on the Judiciary, the Com15 mittee on Armed Service, the Committee on Foreign 

16 Affairs, the Committee on Homeland Security, and 

17 the Permanent Select Committee on Intelligence of 

18 the House of Representatives. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
# L_2022018DE.01013001.xml

| 27.1.2022 | DE | Amtsblatt der Europäischen Union | L 18/130 |
| --- | --- | --- | --- |

27.1.2022

DE

Amtsblatt der Europäischen Union

L 18/130

---

Berichtigung der Verordnung (EU) 2018/669 der Kommission vom 16. April 2018 zur Änderung der Verordnung (EG) Nr. 1272/2008 des Europäischen Parlaments und des Rates über die Einstufung, Kennzeichnung und Verpackung von Stoffen und Gemischen zwecks Anpassung an den technischen und wissenschaftlichen Fortschritt

(
  Amtsblatt der Europäischen Union L 115 vom 4. Mai 2018
  )

Seite 3, Anhang zur Ersetzung bestimmter Einträge in Anhang VI der Verordnung (EG) Nr. 1272/2008, Tabelle Spalte 5 Kopfzeile:

Anstatt:

„Gefahrenklasse, Gefahrenkategorie und Gefahrenkodierung“

muss es heißen:

„Kodierung der Gefahrenklassen und -kategorien“.

---